Boehringer Selling US Generics Arm to Hikima

07.08.2015 - Boehringer Ingelheim, the German drugmaker, has sold its US generics business for $2.7 billion to London-based Jordanian-British owned Hikima Pharmaceuticals. At the same time, it...